Related Experiment Video
Updated: Aug 15, 2026

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Acute stroke: pathophysiology, diagnosis, and treatment
1School of Nursing, La Salle University, Philadelphia, Pennsylvania 19141, USA. Frizzell@Lasalle.edu
Insights
Stroke, a leading cause of death, involves altered cerebral circulation. Early diagnosis and treatments like thrombolytic therapy are crucial for managing ischemic, embolic, and hemorrhagic stroke events.
Area of Science:
- Neurology
- Cardiovascular Science
- Public Health
Background:
- Stroke is the third leading cause of death in the U.S., characterized by altered cerebral circulation.
- Key risk factors include hypertension, family history, and diabetes mellitus.
- Stroke subtypes include ischemic, embolic, and hemorrhagic events, each with distinct pathophysiological mechanisms.
Purpose of the Study:
- To provide an overview of stroke, including its risk factors, subtypes, and diagnostic methods.
- To discuss current treatment strategies, emphasizing thrombolytic therapy for specific stroke types.
- To highlight recommendations for future stroke care and research directions.
Main Methods:
- Review of existing literature on stroke etiology, risk factors, and classification.
- Description of diagnostic tools such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and the National Institutes of Health Stroke Scale (NIHSS).
- Summary of current therapeutic interventions, focusing on thrombolytic agents for ischemic and embolic strokes.
Main Results:
- Ischemic and embolic strokes result from thrombi and emboli due to atherosclerosis, leading to neuronal injury.
- Intracerebral hemorrhage stems from cerebral vessel rupture, often linked to hypertension.
- Diagnosis relies on imaging (CT, MRI) and clinical scales (NIHSS), with treatment tailored to stroke etiology.
Conclusions:
- Thrombolytic therapy is a primary treatment for thrombotic and embolic strokes.
- Future stroke care recommendations emphasize the establishment of specialized stroke centers.
- Ongoing research should explore neuroprotective therapies to improve stroke outcomes.
Abstract:
Stroke, a neurologic event due to altered cerebral circulation, is the third leading cause of death in the United States. Risk factors for stroke include hypertension, family history, and diabetes mellitus. The subtypes of stroke are ischemia, infarction, and hemorrhage. Ischemia and infarction are the result of atherosclerotic development of thrombi and emboli. Decreased and/or absent cerebral circulation causes neuronal cellular injury and death. Intracerebral hemorrhage occurs from rupture of cerebral vessels often as the result of hypertension. Patient assessment and diagnosis include the use of computed tomography scans, magnetic resonance imaging, and the National Institute of Health Stroke Scale, and treatment depends on the etiology of the stroke. Thrombolytic therapy is the mainstay of treatment for thrombotic and embolic events. Current recommendations for future stroke care include the development of designated stroke centers. Directions for research in stroke treatment includes examining neuroprotective therapies.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke l: Introduction

